|
CBA Annual Conference 2019
The Chinese Bioscience Association Annual Conference is coming up on 12 October 2019. Please find the agenda listed below, and register here!
| Opening |
| Time |
Topic |
Speaker |
| 8:00-8:30am |
Registration, Breakfast, Network, and Exhibition |
All |
| 8:30-8:35am |
Welcome Remarks |
AC Chair – Dannis Chang, Pharm.D. |
| 8:35-8:40am |
State of the Union |
President of CBA – Huifang Li, Ph.D. |
| 8:40-9:20am |
Keynote Presentation #1
Brain Tech: The Example of Epilepsy |
Dr. Robert Fisher, MD, PhD. Maslah Saul MD Professor and Director of the Stanford Epilepsy Center and EEG lab, Stanford University |
| Morning Session #1: Innovative Drug Discoveries and Breakthroughs |
| Time |
Topic |
Speaker |
| 9:20-9:25am |
Opening Statements / Introduction of the Speakers |
Session Chair: Wenyi Chen, Ph.D. |
| 9:25-9:50am |
Neuroregeneration Therapies for Neurodegenerative Disorders |
Gong Chen, PhD. Verne M. Willaman Chair Professor, The Pennsylvania State University
Founder and CSO, NeuExcell Therapeutics Inc. |
| 9:50-10:15am |
Integrate CRISPR genome editing and single-cell analysis to probe cancer evolution |
Le Cong, PhD. Stanford Assistant Professor |
| 10:15-10:25am |
Q&A |
ALL |
| 10:25-10:50am |
Break, Network and Exhibition |
| Morning Session #2: Bench to Bedside |
| Time |
Topic |
Speaker |
| 10:50-10:55am |
Opening Statements / Introduction of the Speakers |
Session Chair: Sydney Chen, Ph.D. |
| 10:55-11:20am |
TBD |
Cynthia Wong, VP of Portfolio planning and program management, Denali Therapeutics |
| 11:20-11:45am |
Globalization of First in Human Trials |
Dan Zhang, MD, MPH, Executive Chairman,
Fountain Medical Development, Ltd |
| 11:45-11:55am |
Q&A |
ALL |
| 11:55-12:05pm |
Scholarship Presentation |
| 12:05-1:00pm |
Lunch, Network, and Exhibition |
| Afternoon Opening |
| Time |
Topic |
Speaker |
| 1:00-1:05pm |
Welcome Back, summary of morning sessions |
AC Chair – Dannis Chang, Pharm.D. |
| 1:05-1:45pm |
Keynote Presentation #2 – Do Opposites (Finally) Attract? How Tech is transforming Life Sciences |
Tom Duley, Sidley Austin LLP |
| Afternoon Session #1: AI and Innovative Diagnostic Tools and Technologies To Advancing Healthcare |
| Time |
Topic |
Speaker |
| 1:45-1:50pm |
Opening Statements / Introduction of the Speakers |
Session Chair: Dannis Chang, Pharm.D. |
| 1:50-2:15pm |
TBD |
David Purdie, Ph.D.
Vice President, Medical Affairs and Clinical Development at Proteus Digital Health |
| 2:15-2:40pm |
Generating Efficacious Enzyme Therapeutics based on Knowledge Learned From Biocatalytic Pharmaceutical Manufacture |
Xiang Yi, Ph.D. Scientist and Project leader from Codexis |
| 2:40-3:05pm |
How AI is Transforming the Pharmaceutical and Biotechnology Sectors |
Patricia Campbell, PhD., JD., Partner, Jones Day |
| 3:05-3:15pm |
Q&A |
ALL |
| 3:15-3:30pm |
Break, Network and Exhibition |
| Afternoon Session #2: Trends in Bio-Pharma Drug Development – Global Regulatory Considerations |
| Time |
Topic |
Speaker |
| 3:30-3:35pm |
Opening Statements / Introduction of the Speakers |
Session Chair and Moderator: Lin Sun-Hoffman, PhD, JD |
| 3:35-4:00pm |
Innovative drug regulation:
Soft way to support hard scientific drug-able Innovation |
Frank Li, MD, PhD, Founder and CEO of BLA Regulatory, LLC |
| 4:00-4:30pm |
|
Panelists:
Yong Ben, MD, MBA, CMO of Immuno-Oncology, BeiGene
Frank Li and TBD |
| Afternoon Session #3: Biotech Investment, Deal Transaction and Entrepreneurship Panel |
| Time |
Topic |
Speaker |
| 4:30-4:35pm |
Opening Statements / Introduction of the Speakers |
Session Chair and Moderator: Michelle Chen, PhD |
| 4:35-5:25pm |
|
Panelists:
Alexis Ji (Illumina Ventures), Stella Xu (Quan Capital), Tom Duley (Sidley), Peter Li (Founding CEO of Turning Point Therapeutics) |
| 5:25-5:30pm |
Conference End – Closing Remarks by AC Co-Chair – Wenyi Chen, Ph.D |
| 5:30-7:00pm |
Networking Reception |
|
